Your browser doesn't support javascript.
loading
The effect of Fingolimod on patients with moderate to severe COVID-19.
Teymouri, Soheil; Pourbayram Kaleybar, Siamak; Hejazian, Seyyed Sina; Hejazian, Seyyedeh Mina; Ansarin, Khalil; Ardalan, Mohammadreza; Zununi Vahed, Sepideh.
Affiliation
  • Teymouri S; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Pourbayram Kaleybar S; Kidney Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hejazian SS; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hejazian SM; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ansarin K; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Ardalan M; Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Zununi Vahed S; Kidney Research Center, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
Pharmacol Res Perspect ; 11(1): e01039, 2023 02.
Article in En | MEDLINE | ID: mdl-36567519
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Pharmacol Res Perspect Year: 2023 Document type: Article Affiliation country: Irán Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Pharmacol Res Perspect Year: 2023 Document type: Article Affiliation country: Irán Country of publication: Estados Unidos